How AI-Enabled Real-World Evidence Solutions are Impacting Pharma’s Value Chain
AI is transforming how Real-World Evidence (RWE) solution providers change the way Pharma’s decision making along the value chain. By automating data harmonization and deriving insights from diverse Real-World Data (RWD) sources — including electronic health records, genomics, and wearable devices — AI enables RWE to function as a scalable decision-support engine across research, development, Learn more...
Beyond the Pill: How Pharma Is Redefining Its Value Through AI and HCP-Centric Digital Tools
The rise of AI-enabled “Beyond the Pill” platforms marks a shift from in-house innovation to open collaboration. Pharma companies are co-creating with startups to deliver measurable value for HCPs, patients, and healthcare systems. Pharma’s value proposition is no longer defined solely by the pill. Today, the industry is stepping into a broader, technology-driven role, one Learn more...
Interview with Henro van Rooyen, Regional Lead, EMEA, TrialScreen
Patient recruitment and retention remain critical bottlenecks in clinical research, causing delays in the majority of trials and driving up the cost of drug development. As the market shifts toward decentralized and hybrid models, sponsors are seeking scalable, patient-friendly solutions that balance speed with precision. One company stepping into this space is TrialScreen, a global, Learn more...
Digital Longevity: Business Models Defining the Next HealthTech Wave
In 2024, global funding for the digital longevity sector reached several billion dollars, underscoring investor confidence in startups that aim not just to treat disease but to extend healthy lifespan. The offerings span biomarkers, preventive health, early detection, therapeutic discovery, and at-home monitoring. But funding only tells part of the story. Investors and strategic partners Learn more...
Digital Longevity in 2035: Market Size and Opportunity
Digital longevity software, data, and connected devices focused on extending healthspan rather than just treating disease sit at the intersection of digital health, age-tech, diagnostics, and preventive care. The overall addressable market is substantial, but how much can digital longevity solutions realistically capture over the long term? While expectations are high, key questions remain: how Learn more...
Digital Longevity: From Hype to HealthTech’s Next Investment Magnet
For many, “longevity” still suggests supplements or wellness retreats. In reality, the sector is becoming one of the fastest-growing segments of digital health. The new generation of longevity solutions is built on biomarker platforms, AI-driven diagnostics, preventive health coaching, and continuous at-home monitoring. Together, they promise not just longer lives, but healthier years — and Learn more...
New Report: Companion App Market Set to Grow Tenfold, Reaching $20B Revenue Uplift by 2029
New R2G report. Integrated drug-app-service bundles are reshaping patient support and commercial strategy in pharma. 3,000 companion apps will help Pharma to generate $20B of incremental revenues by 2029. Selecting the right drugs is essential for the success of companion apps. Research2Guidance has published its latest market report, “The Rise of Companion Apps: A $20B Learn more...
Pitch First, Pilot Later: What Startups Want From Partnerships
HealthTech startups are clear about what they need most from partnerships, and it’s not just mentorship. In the race to scale HealthTech innovations, no startup succeeds in a vacuum. From fundraising to pilot programs, commercial traction to co-development, the path to market is increasingly shaped by who you work with, not just what you build. Learn more...
The $1M Revenue Club: What Sets These HealthTech Startups Apart?
73% of HealthTech companies generate revenue. Thereof only 19% of HealthTech startups make more than $1 million a year. So, what are they doing that others aren’t? The HealthTech sector is booming, with thousands of startups worldwide building digital tools to reshape healthcare. But when it comes to financial performance, most are still chasing their Learn more...